Additionally, the involvement of resting CD4 memory T cells suggests a potential dysregulation of adaptive immunity in MYCN‐amplified NB, indicating a mechanism by which the tumor evades immune surveillance [44]. The gene discussed is MYCN; the disease is neuroblastoma.